Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated July 04, 2024, titled "Validation of Nidlegy Marketing Authorization Application Submission by EMA".
Press Release Jul 04 2024
Filed with NSE ·
6ix hasn’t read this filing yet.
Sun Pharmaceutical Industries Limited on 6ix
Earlier from Sun Pharmaceutical Industries
- Press Release Jun 24 2024
- Press Release Jun 22 2024
- Press Release Jun 21 2024
- Sun Pharma - Oral Presentation at EULAR 2024 of Data from Global Phase 2b Clinical Trial Demonstrates Durability of Pain Relief After a Single Injection of MM-II in Patients with Painful Knee Osteoarthritis
- Press Release Jun 14 2024
Later from Sun Pharmaceutical Industries
- Press Release Jul 16 2024
- Sun Pharmaceutical Industries Limited Press Release Jul 26 2024
- Press Release Aug 23 2024
- Press Release Sep 06 2024
- Sun Pharma and Moebius Medical Announce Fast Track Designation Granted for MM-II for the Treatment of Osteoarthritis Knee Pain
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries